6th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

he problems and prospects in IO research will be covered at our 7th ANNUAL MARKETSANDMARKETS NEXT GEN IMMUNO-ONCOLOGY CONFERENCE, which will be held in London on March 9–10, 2023. Academics, researchers, and scientists from pharmaceutical, biopharmaceutical, and biotechnology businesses will be present at the congress to discuss the most recent advancements in the creation of ADCs, Bispecific Antibodies, Cellular Therapy, and Immune Checkpoint Inhibitors.CONFERENCE REGISTRATION: https://events.marketsandmarkets.com/6th-annual-immuno-oncology-conference-boston/register [https://events.marketsandmarkets.com/6th-annual-immuno-oncology-conference-boston/register]  Several combination techniques, pre-clinical and translational immune-oncology advancements, updates in cellular and viral therapeutics, vaccine development, and personalized immunotherapy would also be covered during this congress. The keynote addresses, brainstorming panel discussions, and case studies will provide the stakeholders with the chance to talk about and comprehend the problems they are facing as well as develop solutions. To know more details about the combined packages and offers at the Co-located events write to us at events@marketsandmarkets.com.